Europe Broadens Covid Shot and Booster Access for Children

Feb. 24, 2022, 4:03 PM UTC

The European Union’s drugs regulator cleared new Covid-19 vaccine options for children, recommending approval of Moderna Inc.’s shot for a younger age group and green-lighting boosters of the Pfizer Inc.-BioNTech SE immunization for teens.

The moves by the European Medicines Agency on Thursday broaden the options for age groups that have seen soaring case rates as the omicron variant sweeps the continent. The agency recommended a Pfizer-BioNTech booster “where appropriate” for children from age 12, after clearing the first two doses of the shot for the same age group last May.

The Moderna approval will cover children 6 ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.